BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27816054)

  • 1. Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.
    Machahua C; Montes-Worboys A; Llatjos R; Escobar I; Dorca J; Molina-Molina M; Vicens-Zygmunt V
    Respir Res; 2016 Nov; 17(1):144. PubMed ID: 27816054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nε-Carboxymethyl-Lysine Modification of Extracellular Matrix Proteins Augments Fibroblast Activation.
    Ediga HH; Hester P; Yepuri A; Reddy GB; Madala SK
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.
    Kyung SY; Byun KH; Yoon JY; Kim YJ; Lee SP; Park JW; Lee BH; Park JS; Jang AS; Park CS; Jeong SH
    Int J Clin Exp Pathol; 2014; 7(1):221-8. PubMed ID: 24427342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
    Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
    BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
    Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
    BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-κB activation.
    Tian Y; Li H; Qiu T; Dai J; Zhang Y; Chen J; Cai H
    Aging Cell; 2019 Feb; 18(1):e12858. PubMed ID: 30548445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen 3D matrices as a model for the study of cell behavior in pulmonary fibrosis.
    Machahua C; Vicens-Zygmunt V; Ríos-Martín J; Llatjós R; Escobar-Campuzano I; Molina-Molina M; Montes-Worboys A
    Exp Lung Res; 2022 Apr; 48(3):126-136. PubMed ID: 35594338
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition.
    Song JS; Kang CM; Park CK; Yoon HK; Lee SY; Ahn JH; Moon HS
    Exp Mol Med; 2011 Sep; 43(9):517-24. PubMed ID: 21743278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEMA3B inhibits TGFβ-induced extracellular matrix protein production and its reduced levels are associated with a decline in lung function in IPF.
    Yombo DJK; Ghandikota S; Vemulapalli CP; Singh P; Jegga AG; Hardie WD; Madala SK
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1659-C1668. PubMed ID: 38646784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways.
    Chen B; Cai HR; Xue S; You WJ; Liu B; Jiang HD
    Respirology; 2016 Aug; 21(6):1075-80. PubMed ID: 27185272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased alveolar soluble annexin V promotes lung inflammation and fibrosis.
    Buckley S; Shi W; Xu W; Frey MR; Moats R; Pardo A; Selman M; Warburton D
    Eur Respir J; 2015 Nov; 46(5):1417-29. PubMed ID: 26160872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of miR-200 in pulmonary fibrosis.
    Yang S; Banerjee S; de Freitas A; Sanders YY; Ding Q; Matalon S; Thannickal VJ; Abraham E; Liu G
    Am J Pathol; 2012 Feb; 180(2):484-93. PubMed ID: 22189082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced receptor for advanced glycation end products is associated with α-SMA expression in patients with idiopathic pulmonary fibrosis and mice.
    Baek H; Jang S; Park J; Jang J; Lee J; Hong SH; Kim WJ; Park SM; Yang SR
    Lab Anim Res; 2021 Oct; 37(1):28. PubMed ID: 34600594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts.
    Nizamoglu M; Alleblas F; Koster T; Borghuis T; Vonk JM; Thomas MJ; White ES; Watson CK; Timens W; El Kasmi KC; Melgert BN; Heijink IH; Burgess JK
    Acta Biomater; 2024 Mar; 177():118-131. PubMed ID: 38350556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways.
    Xu X; Chen H; Zhu X; Ma Y; Liu Q; Xue Y; Chu H; Wu W; Wang J; Zou H
    Clin Exp Immunol; 2013 Sep; 173(3):523-35. PubMed ID: 23682982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
    Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
    Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.
    Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA
    Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM72 promotes alveolar epithelial cell membrane repair and ameliorates lung fibrosis.
    Cong X; Nagre N; Herrera J; Pearson AC; Pepper I; Morehouse R; Ji HL; Jiang D; Hubmayr RD; Zhao X
    Respir Res; 2020 May; 21(1):132. PubMed ID: 32471489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.